Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Amorphex Therapeutics Logo
Amorphex Therapeutics Growth Score
24
CB Rank
189408
Heat Score
17
Amorphex Therapeutics develops a platform technology for ocular drug delivery.
Founded
obfuscation
PrivateSeed Andover, Massachusetts, United States1-10 www.amorphexusa.com/
Health Care
Medical
Medical Device
Overview

Amorphex Therapeutics
Total Funding
obfuscation
Growth Score
24
Heat Score
17

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score24
-4 pts
in past quarter
Heat Score 17
-17 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Amorphex Therapeutics

CB Rank
189408
Amorphex Therapeutics develops a platform technology for ocular drug delivery.
Founded
obfuscation
PrivateSeed Andover, Massachusetts, United States1-10 www.amorphexusa.com/
Health Care
Medical
Medical Device

Funding Rounds

Seed
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation

Details

Legal Name Amorphex Therapeutics Holdings Inc
Operating Status Active
Company Type For Profit
About the Company
Amorphex Therapeutics develops a platform technology for ocular drug delivery. It has developed TODDD™, a soft, patented device that can deliver drugs to the eye continuously, around the clock for multiple months without interruption.
Phone Number 978-475-4491
Predictions & Insights

Products & Services

TODDD™
A soft, non-invasive ocular insert that delivers drugs continuously to the eye for weeks or months without interruption.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Amorphex Therapeutics Logo
Seed Round - Amorphex Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Amorphex Therapeutics Logo
Seed Round - Amorphex Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Amorphex Therapeutics Logo
Seed Round - Amorphex Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Amorphex Therapeutics Logo
Seed Round - Amorphex Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Amorphex Therapeutics Logo
Seed Round - Amorphex Therapeutics
—
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Amorphex Therapeutics Logo
Seed Round - Amorphex Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Amorphex Therapeutics Logo
Seed Round - Amorphex Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Amorphex Therapeutics Logo
Seed Round - Amorphex Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Amorphex Therapeutics Logo
Seed Round - Amorphex Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Amorphex Therapeutics Logo
Seed Round - Amorphex Therapeutics
—
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Aug 8, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$16.4KThis year, Amorphex Therapeutics is projected to spend $16.4K on IT, according to Aberdeen.

Active Website Tech Count

16Amorphex Therapeutics is actively using 16 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, HSTS, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Amorphex Therapeutics's headquarters? Amorphex Therapeutics is located in Andover, Massachusetts, United States.When was the last funding round for Amorphex Therapeutics? Amorphex Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Amorphex Therapeutics's competitors? Alternatives and possible competitors to Amorphex Therapeutics may include AbbVie, Bausch & Lomb, and  Sun Pharmaceutical.How much funding has Amorphex Therapeutics raised to date? Amorphex Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|